| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vivos Therapeutics (NASDAQ:VVOS) through any online brokerage.
Other companies in Vivos Therapeutics’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
Vivos Therapeutics has a consensus price target of $3.87.
The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $0.130522 last updated October 21, 2026 at 7:52 PM EDT.
There are no upcoming dividends for Vivos Therapeutics.
Vivos Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Vivos Therapeutics.
Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
